EGFR In Non-Small Cell Lung Carcinoma

Around 10-35% of non-small cell lung carcinomas have drug-sensitizing mutations in the epidermal growth factor receptor (EGFR) gene. In these cases, tyrosine kinase inhibitor therapy is recommended. Find the latest research on EGFR and non-small cell lung carcinoma here.

May 30, 2020

Reduced sensitivity for EGFR T790M mutations using the Idylla EGFR Mutation Test

Journal of Clinical Pathology
Eric LeeJames Harraway
May 26, 2020

Molecular Diagnostics in Non-Small Cell Lung Carcinoma

Seminars in Respiratory and Critical Care Medicine
Lynette M Sholl
May 29, 2020

Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review

Journal of Cancer Research and Clinical Oncology
Stepan M EsagianKonstantinos P Economopoulos
May 21, 2020

Management of a patient with a double EGFR and MET anomaly by combined treatment

Revue des maladies respiratoires
L JénotJ Mazieres
May 27, 2020
Open Access

Miliary lung metastases from ROS1-rearranged lung adenocarcinoma: A case report

Molecular and Clinical Oncology
Ryota OtoshiOgura Takashi
May 20, 2020

Effect of epidermal growth factor receptor mutation on early-stage non-small cell lung cancer according to the 8th TNM classification

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Tetsuya IsakaMunetaka Masuda
June 1, 2020

Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Shu Qiao ZhangXin Yu Li
May 21, 2020

EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer

Cancer Discovery
Vito AmodioSandra Misale
May 25, 2020

Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jeemin YimDoo Hyun Chung
May 29, 2020
Open Access

Current status and future perspectives of liquid biopsy in non-small cell lung cancer

Journal of Pathology and Translational Medicine
Sunhee ChangWan Seop Kim
May 28, 2020

Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Jamie J BeaganDaniëlle A M Heideman

Sign up to follow this feed and discover related papers.

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.

Large Cell Carcinoma of Lung

Large Cell Carcinoma of Lung is a non-small cell lung cancer that is characterized histologically by large malignant cells. Symptoms include fatigue and shortness of breath. Discover the latest research on Large Cell Carcinoma of Lung here.

Lung Adenocarcinoma

Lung adenocarcinoma is a type of non-small cell lung cancer and is the most frequent histological type of lung cancer, often triggered by aberrations in a driver oncogene. Here is the latest research.

Lung Squamous Cell Carcinoma

Lung squamous cell carcinomas represent 30% of all lung cancers. This feed focuses on genetic and environmental factors that affect this cancer, as well as current therapeutic strategies. Here is the latest research.

Meningeal Carcinomatosis

Meningeal carcinomatosis is a type of cancer that is spread into the leptomeninges within the brain, which are the inner two meningeal layers surrounding the brain. The most common types of cancer that spread to the leptomeninges via the CSF are breast cancer, melanoma and lung cancer. Here is the latest research on meningeal carcinomatosis.

Multiple Pulmonary Nodules

Multiple pulmonary nodules occur when there are two or more lesions that are 2-3 mm diameter. The most common source of the nodules is from cancer that has metastasized to the lungs. Other causes may be from benign tumors, autoimmune disorders, infection scars, enlarged lymph nodes and others. Here is the latest research on multiple pulmonary nodules.

Pleural Effusion, Malignant

When fluid accumulates within the pleural space, the area between the lungs and chest wall can contain malignant cells or tumor tissues, resulting from a malignant pleural effusion. The malignant cells often arise from metastasized cancer, most commonly breast cancer and lung cancer, Here is the latest research on malignant pleural effusions.

Small Cell Lung Carcinoma

Small cell lung carcinoma is a specific type of cancer that originates the lungs and is highly malignant. The type of cancer is determined by the distinctive cell type when viewed under a microscope. Here is the latest research on small cell lung carcinoma.

© 2020 Meta ULC. All rights reserved